Outpatient Pain Control
Outpatient Pain Control - Related Videos
11:34
Breathing-controlled Electrical Stimulation (BreEStim) for Management of Neuropathic Pain and Spasticity
0 Views •
Cited by 9 •
2013
The purpose is to present a new method, breathing-control electrical stimulation (BreEStim) for management of neuropathic pain and spasticity.
14:56
An Experimental Paradigm for the Prediction of Post-Operative Pain (PPOP)
0 Views •
Cited by 107 •
2010
Diffuse noxious inhibitory control, temporal summation and wound hyperalgesia testing are demonstrated in the obstetric patient. These tests evaluate inhibitory and excitatory mechanisms of pain processing and are here utilized to evaluate endogenous analgesia at different time-points during pregnancy and the peripartum period to help reveal individual s risk for persistent pain.
07:39
Subcutaneous Trigeminal Nerve Stimulation to Relieve Neuropathic Facial Pain
0 Views •
2025
Source: Jakobs, M., et al. Subcutaneous Trigeminal Nerve Field Stimulation for Refractory Facial Pain. J. Vis. Exp. (2017)This procedure demonstrates the implantation of subcutaneous electrodes for trigeminal nerve stimulation to treat neuropathic facial pain. The electrodes are tunneled subcutaneously from the affected facial region to an infraclavicular pocket, where they are connected to an internal pulse generator (IPG). The IPG delivers electrical stimulation, activating mechanoreceptor...
14:49
Conducting Respiratory Oscillometry in an Outpatient Setting
0 Views •
Cited by 6 •
2022
We demonstrate a standard operating protocol to conduct respiratory oscillometry, highlighting key quality control and assurance procedures.
01:34
Early Intervention and Pain Management
0 Views •
2026
All animal procedures described here must be conducted in accordance with institutional animal ethics guidelines and approved by IACUC. All procedures must follow the principles of the 3Rs—Replacement, Reduction, and Refinement—and must be performed by trained personnel. Monitoring Animals for Signs of Pain and Distress Recognizing early signs of pain is essential for ethical animal research. Animals are routinely monitored using behavioral, physical, and physiological parameters that reflect...
FAQs
Multimodal regimens combine medicines that act at different points in pain processing. Nonopioid drugs can reduce inflammatory signaling or central pain processing, local anesthetics can interrupt nerve conduction, and opioids can alter pain perception through receptor activation. Using complementary mechanisms may improve comfort while limiting opioid exposure, which can reduce preventable medication-related complications.
Local anesthetics act directly on nerves by blocking sodium channels and preventing nerve conduction. Opioids instead activate receptors that change how pain is perceived and how the body responds to it. Nonopioid medicines may reduce inflammatory signaling or central pain processing. These distinct mechanisms help pharmacology match treatment components to the patient’s pain needs.
Pain intensity, individual patient factors, and the risk of adverse effects all influence medication selection. Pharmacology uses these considerations to guide the choice of drug classes, dosing, and treatment duration. The same approach also supports monitoring after discharge, because a regimen must balance effective relief with safe self-administration and reduced medication-related risk.
Before discharge, the plan should establish which medicines are appropriate, how they should be dosed, and how long they should be used. It should also account for pain intensity, patient-specific considerations, and adverse-effect risk. Clear attention to monitoring supports safe self-administration and helps maintain effective relief during recovery at home.
A multimodal regimen is relevant when outpatient pain requires more than one pharmacologic mechanism to achieve adequate relief. Combining nonopioid medicines, local anesthetics, or opioids can address different aspects of pain processing. This strategy is particularly useful when clinicians aim to support recovery while limiting opioid exposure and reducing preventable medication-related complications.
Outpatient pain control is evaluated by how well it relieves pain, supports safe self-administration, and limits medication-related complications. Pharmacologic planning also considers whether dosing and treatment duration fit the patient’s needs. In practice, these outcomes connect drug mechanisms with recovery after a procedure, injury, or treatment, especially when monitoring continues after discharge.